European Journal of Pharmacology 1995-12-04

Receptor binding profile of cyclazosin, a new alpha 1B-adrenoceptor antagonist.

D Giardinà, M Crucianelli, C Melchiorre, C Taddei, R Testa

文献索引:Eur. J. Pharmacol. 287 , 13-16, (1995)

全文:HTML全文

摘要

The binding profile of cyclazosin, a new prazosin-related alpha 1-adrenoceptor antagonist, at alpha 1-, alpha 2-adrenoceptors, dopamine D2 and 5-HT1A receptors was compared to that of 5-methylurapidil, spiperone, risperidone and other prazosin-related ligands. In addition, cyclazosin was investigated at native and cloned alpha 1-adrenoceptor subtypes. Cyclazosin showed high specificity for alpha 1-adrenoceptors and a 10-15-fold selectivity for alpha 1B (alpha 1b)-adrenoceptors with respect to the alpha 1A (alpha 1a) subtype (pKi values of 9.23-9.57 and 8.18-8.41, respectively). However, it failed to discriminate between cloned alpha 1b and alpha 1d-adrenoceptors (pKi values of 9.23 and 9.28, respectively).


相关化合物

  • 胞磷胆碱

相关文献:

Synthesis and biological profile of the enantiomers of [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin- 1-yl]furan-2-ylmethanone (cyclazosin), a potent competitive alpha 1B- adrenoceptor antagonist.

1996-11-08

[J. Med. Chem. 39 , 4602, (1996)]

更多文献...